Agios Pharmaceuticals, Inc.
AGIO
$33.50
$0.912.79%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.61% | 8.26% | -4.45% | 7.67% | -25.46% |
| Total Depreciation and Amortization | -0.95% | 7.66% | -7.86% | 9.13% | -1.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 144.33% | 16.35% | 7.15% | -44.23% | 94.62% |
| Change in Net Operating Assets | 97.35% | -745.29% | -1,887.01% | -102.79% | 122.69% |
| Cash from Operations | 51.81% | -23.60% | -9.15% | -14.30% | 30.82% |
| Capital Expenditure | -57.61% | 31.34% | 27.97% | -77.71% | -14.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -70.85% | 55.80% | -6.09% | 21.63% | -29.56% |
| Cash from Investing | -71.55% | 56.88% | -5.73% | 21.01% | -29.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 51.54% | -18.73% | -42.34% | 6,723.08% | -95.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 51.54% | -18.73% | -42.34% | 6,723.08% | -95.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -157.02% | 783.52% | -130.24% | 520.82% | -29.81% |